Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Advanced Life Sciences Holdings, Inc.

http://www.advancedlifesciences.com

Latest From Advanced Life Sciences Holdings, Inc.

Arrowhead’s Focus On Plozasiran Intensifies Competition With Ionis

Arrowhead’s in-house, late-stage cardiovascular disease programs will center on triglyceride-lowering plozasiran while it seeks a partner to fund Phase III for cholesterol-reducing zodasiran.

Cardiovascular Rare Diseases

First Phase III Success Opens Up Cardiovascular Pathway For Arrowhead

Arrowhead could have its first in-house RNA therapy on the market by 2025, with big plans to expand its reach in cardiometabolic disease, following a pivotal trial hit.

Companies Commercial

Epitel Gets 510(k) Clearance On Remote EEG Technology

The REMI Remote EEG monitoring system and REMI Vigilenz AI could help patients with infrequent seizures get a quicker diagnosis.

Approvals FDA

Takeda Charges Into Diversification With ITP Win

The company announced positive topline results from a Phase II study of mezagitamab and expects to have five programs in Phase III development this fiscal year.

Clinical Trials Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
UsernamePublicRestriction

Register